LRRK2 and Parkinson disease: The data provided here also suggest the LRRK2 mutation alone is not sufficient to increase CSF LRRK2 since the PD- LRRK2+ group did not have significantly elevated levels compared to the healthy controls or the sporadic PD group, though a trend was observed.